Market Research Logo

Pakistan Pharmaceuticals and Healthcare Report Q2 2016

Pakistan Pharmaceuticals and Healthcare Report Q2 2016

BMI View: A challenging business environment will perpetuate the fragmented and underdevelopedpharmaceutical market in Pakistan. Patent protection in the country is poor, dissuading local firms frominvesting into research and multinational drugmakers from launching new innovative treatments in thecountry. Moreover, the country has a tough pricing environment and an equally challenging distributionsystem which will continue to hinder the growth of pharmaceutical firms. Consequently, Pakistan-baseddrugmakers will focus on overseas markets where higher margins present stronger opportunities forgrowth.

Headline Expenditure Projections

Pharmaceuticals: PKR252bn (USD2.4bn) in 2015 to PRK273bn (USD2.5bn) 2016; +8.2%in localcurrency terms and +5.1% in US dollar terms.

Healthcare: PKR725bn (USD7bn) in 2015 to PKR804bn (USD7.6bn) in 2016; +11% in local currencyterms and +7.6% in US dollar terms.


BMI Industry View
Table: Headline Pharmaceuticals & Healthcare Forecasts (Pakistan 2014-2020)
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Pakistan 2012-2020)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Pakistan 2012-2020)
Table: Government Healt Expenditure Trends, Historical Data And Forecasts (Pakistan 2010-2018)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Pakistan 2012-2020)
Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Pakistan 2012-2020)
Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Pakistan 2012-2020)
Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Pakistan 2012-2020)
OTC Medicine Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Pakistan 2012-2020)
Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Pakistan 2014-2020)
Table: Pharmaceutical Trade Data And Forecasts local currency (Pakistan 2014-2020)
Industry Risk/Reward Index
Asia Pacific Risk/Reward Index
Pakistan Risk/Reward Index
Rewards
Risks
Regulatory Review
Regulatory Developments
Intellectual Property Issues
Pricing Regime
Reimbursement Regime
Market Overview
Healthcare Sector
Table: Healthcare Resources (Pakistan 2010-2015)
Table: Healthcare Personnel (Pakistan 2010-2015)
Table: Healthcare Activity (Pakistan 2010-2015)
Research & Development
Clinical Trials
Epidemiology
Table: Diabetic Patients' Education Level & Compliance Levels
Table: Estimated Number Of New Cases Of Cancer In Pakistan
Table: Frequency Of Information Provided To Patients As A Percentage Of Total Cases
Competitive Landscape
Research-Based Industry
Table: Multinational Market Activity
Generic Drugmakers
Table: PPMA As Of 2015
Pharmaceutical Distribution
Company Profile
Abbott Laboratories
Efroze Chemical Industries
Ferozsons Laboratories
Getz Pharma
GlaxoSmithKline (GSK)
Hilton Pharma
Novartis
Pfizer
Sanofi-Aventis
Searle Pakistan Limited
Demographic Forecast
Table: Population Headline Indicators (Pakistan 1990-2025)
Table: Key Population Ratios (Pakistan 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Pakistan 1990-2025)
Table: Population By Age Group (Pakistan 1990-2025)
Table: Population By Age Group % (Pakistan 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators
Indicator Weightings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report